Third Eye Diagnostics, Inc.
Novel medical device to non-invasively measure intracranial pressure, critical in assessing the extent of traumatic brain injury and management of hydrocephalus
3ED has developed a breakthrough medical device to non-invasively measure intracranial pressure (ICP), which is critical in evaluating the onset & extent of traumatic brain injury and in the management of hydrocephalus.
• Funded & technically validated by National Science Foundation
• Prototype ready for clinical trial at UPenn, Dept. Neurocritical Care
• High margin/volume recurring revenue
• $21B TAM
• 4 patents and 1 pending applications